Neuroendocrine Determinants of Polycystic Ovary Syndrome

Int J Environ Res Public Health. 2022 Mar 6;19(5):3089. doi: 10.3390/ijerph19053089.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women and a major cause of anovulatory infertility. A diagnosis of PCOS is established based the presence of two out of three clinical symptoms, which are criteria accepted by the ESHRE/ASRM (European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine). Gonadotropin-releasing hormone (GnRH) is responsible for the release of luteinizing hormone, and follicle stimulating hormone from the pituitary and contributes a leading role in controlling reproductive function in humans. The goal of this review is to present the current knowledge on neuroendocrine determinations of PCOS. The role of such neurohormones as GnRH, and neuropeptides kisspeptin, neurokinin B, phoenixin-14, and galanin is discussed in this aspect. Additionally, different neurotransmitters (gamma-aminobutyric acid (GABA), glutamate, serotonin, dopamine, and acetylcholine) can also be involved in neuroendocrine etiopathogenesis of PCOS. Studies have shown a persistent rapid GnRH pulse frequency in women with PCOS present during the whole ovulatory cycle. Other studies have proved that patients with PCOS are characterized by higher serum kisspeptin levels. The observations of elevated serum kisspeptin levels in PCOS correspond with the hypothesis that overactivity in the kisspeptin system is responsible for hypothalamic-pituitary-gonadal axis overactivity. In turn, this causes menstrual disorders, hyperandrogenemia and hyperandrogenism. Moreover, abnormal regulation of Neurokinin B (NKB) is also suspected of contributing to PCOS development, while NKB antagonists are used in the treatment of PCOS leading to reduction in Luteinizing hormone (LH) concentration and total testosterone concentration. GnRH secretion is regulated not only by kisspeptin and neurokinin B, but also by other neurohormones, such as phoenixin-14, galanin, and Glucagon-like peptide-1 (GLP-1), that have favorable effects in counteracting the progress of PCOS. A similar process is associated with the neurotransmitters such as GABA, glutamate, serotonin, dopamine, and acetylcholine, as well as the opioid system, which may interfere with secretion of GnRH, and therefore, influence the development and severity of symptoms in PCOS patients. Additional studies are required to explain entire, real mechanisms responsible for PCOS neuroendocrine background.

Keywords: KNDy; PCOS; kisspeptin; neurokinin b; phoenixin.

Publication types

  • Review

MeSH terms

  • Acetylcholine / therapeutic use
  • Dopamine
  • Female
  • Galanin / therapeutic use
  • Glutamic Acid
  • Gonadotropin-Releasing Hormone
  • Humans
  • Kisspeptins
  • Luteinizing Hormone
  • Neurokinin B / therapeutic use
  • Neurotransmitter Agents
  • Polycystic Ovary Syndrome*
  • Serotonin
  • United States
  • gamma-Aminobutyric Acid

Substances

  • Kisspeptins
  • Neurotransmitter Agents
  • Serotonin
  • Gonadotropin-Releasing Hormone
  • Glutamic Acid
  • gamma-Aminobutyric Acid
  • Neurokinin B
  • Galanin
  • Luteinizing Hormone
  • Acetylcholine
  • Dopamine